Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Immunology

Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 Last 

California

Children's Hospital of Orange County
Orange California 92868

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

University of California San Francisco Medical Center - Parnassus
San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Colorado

Children's Hospital Denver
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

District of Columbia

Children's National Medical Center
Washington District of Columbia 20310

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Georgia

Children's Healthcare of Atlanta-Egleston
Atlanta Georgia 30307

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Children's Healthcare of Atlanta at Egleston
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Illinois

Northwestern University
Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Indiana

Riley Hospital for Children
Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical research study of bortezomib and rituximab for the treatment of Post-transplant Lymphoproliferative Disease, Solid Organ Transplant, Stem Cell Transplant (Bone Marrow Transplant) or Epstein Barr Virus Infections

Michigan

Detroit Clinical Research Center, PC
Novi Michigan 48377

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Missouri

Washington University School of Medicine
St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Washington University
ST. Louis Missouri

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

New York

Columbia University Medical Center
New York New York 10032

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Memorial Sloan Kettering
New York New York 10065

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Memorial Sloan-Kettering Cancer Center
New York New York 10065

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

New York Presbyterian Hospital
New York New York 10021

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Ohio

Cincinnati Children's Hospital Medical Center
Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Cincinnati Children's Hospital Medical Center
Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Rainbow Babies & Children's Hospital
Cleveland Ohio 44106

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Pennsylvania

Children's Hospital of Philadelphia
Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Children's Hospital of Philadelphia
Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Children's Hospital of Pittsburgh of UPMC
Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Tennessee

Saint Jude Children's Research Hospital
Memphis Tennessee 38105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

St Jude Children's Research Hospital
Memphis Tennessee 38105-3678

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Texas

UT Southwestern Medical Center
Dallas Texas 75390-9063

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Baylor College of Medicine
Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Texas Children's Cancer Center/ Baylor
Houston Texas 77030-2399

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

UT MD Anderson Cancer Center
Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Utah

Primary Children's Medical Center
Salt Lake City Utah

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Washington

Seattle Children's Hospital
Seattle Washington 98105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Seattle Children's Hospital
Seattle Washington 98105

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Wisconsin

Midwest Children's Cancer Center
Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Australia

Royal Adelaide Hospital
Adelaide South Australia 5000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Flinders Medical Center
Bedford Park South Australia 5042

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Monash Medical Centre
Clayton Victoria 3168

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Saint Vincent's Hospital Melbourne
Fitzroy Victoria 3109

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Frankston Hospital
Frankston Victoria 3199

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

View More »

Royal Hobart Hospital
Hobart Tasmania 7001

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Cabrini Health
Malvern Victoria 3144

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Royal Perth Hospital
Perth Western Australia 6000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Austria

St. Anna Kinderspital
Vienna 1090

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Belgium

AZ Sint-Jan
Brugge 8000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Universitair Ziekenhuis Gent
Gent 9000

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Canada

Hôpital du Sacré-Coeur de Montréal
Montreal Quebec H4J 1C5

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Sunnybrook Health Science Centre
Toronto Ontario M4N 3M5

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

France

Hôpital Morvan
Brest 29609

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Hôpital de la Timone (Enfants)
Marseille

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Hopital Robert Debré (AP-HP)
Paris Cedex 19 75935

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

CHU Haut-Leveque
Pessac 33604

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Germany

Charité Campus Virchow Klinikum, Otto-Heubner-Centrum (OHC) für Kinder- und Jugendmedizin
Berlin 13353

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

First 1 2 3 Last